PharmaBoardroom

Top 8 Polish Pharma Companies Ranking 2019

Every year, Polish news magazine Wprost publishes its ranking of the top 200 Polish companies across all industries. Eight pharma-related companies…

Alternative Models of Industry-Academia Research Collaboration in…

Hungary’s longstanding tradition of pharmacology is a major point of pride for the country’s scientists and researchers who today have hopes to…

How Hungary is Maintaining its Clinical Research Reputation

According to Peter Holchacker, director general of Hungary’s Association of Innovative Pharmaceutical Manufacturers (AIPM), “clinical trials…

Deepak Khanna – SVP & Regional President Oncology…

Speaking at the 2020 European Cancer Forum in Brussels, MSD’s Deepak Khanna outlines the progress that the company is making at the forefront of…

Company Spotlight: Medi-Radiopharma

Established in 1997, Medi-Radiopharma is a Hungarian privately held company operating in the field of nuclear medicine, a specialized area of…

Pharma Faces: Anna Wienner, IBSA Hungary

As general manager of the Hungarian affiliate of Swiss firm IBSA, Anna Wienner has proven herself to be a motivated pharma leader with particular…

The US Healthcare Insurance Industry Hits Back

In 2019, several drug companies testified to the US Senate Finance Committee on medicine price hikes with a narrative of discounts given to health…

Diana Mereu – CEO, Romanian Association of the Self-Care…

The Romanian Association of the Self-Care Industry (RASCI) was established in 2016 as the “voice” of the Romanian consumer healthcare industry.…

Gulf Healthcare Costs to Rise Drastically in 2020

Growing incidence of lifestyle-related diseases, coupled with high drug prices, are driving up healthcare costs at astounding rates in the Middle East…

The UAE: Becoming a Global Pharma Management Hub

From Turkey to Tajikistan, Bangladesh to Bahrain, and Russia to Rwanda, multinational pharma firms are increasingly situating wide-ranging management…

Milan Černek – Country Manager, Mylan Czech Republic

Milan Černek, country manager of Mylan in the Czech Republic, provides expert insights into current trends in the Czech Republic’s generics and…

China Biosimilar Market Snapshot

Biosimilars are a relatively recent development in the pharmaceutical industry, meaning market penetration is still fairly low, even in many developed…

Tagged with